Raleigh Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-92
| Closed | -$7.87K | – | 873 |
|
|
2024
Q4 | $7.87K | Hold |
92
| – | – | ﹤0.01% | 641 |
|
|
2024
Q3 | $10.9K | Buy |
92
+1
| +1% | +$118 | ﹤0.01% | 573 |
|
|
2024
Q2 | $13K | Hold |
91
| – | – | 0.01% | 521 |
|
|
2024
Q1 | $11.7K | Hold |
91
| – | – | 0.01% | 530 |
|
|
2023
Q4 | $9.39K | Hold |
91
| – | – | ﹤0.01% | 605 |
|
|
2023
Q3 | $8.26K | Buy |
91
+1
| +1% | +$91 | ﹤0.01% | 582 |
|
|
2023
Q2 | $7.32K | Hold |
90
| – | – | ﹤0.01% | 550 |
|
|
2023
Q1 | $7.16K | Buy |
+90
| New | +$7.16K | ﹤0.01% | 565 |
|